Dr. Lebwohl: Yes, the JDD definitely fills a niche. There are articles that simply would not appear if JDD weren't there. It manages to get a good mix of articles that need to get published but may not be priority for the other leading journals. The JDD publishes positive as well as negative data, which I think is very important and provides an incredibly valuable resource for dermatologists.
Dr. Lebwohl: I especially enjoy the special topic articles being combined into one issue. It is interesting to read a series of articles on related topics and there are always other subjects mixed in as well, so there is variety in every issue and there are articles in every issue that are of interest to me.
Dr. Lebwohl: Yes, the JDD has become one of the more important journals in dermatology. Certainly, when pharmaceutical companies have new data on their products, they look to publish in the JDD. The editors have worked hard to establish JDD as an important component of the dermatologic literature and whenever you meet Perry Robins and Jim Spencer, it is very clear that getting good articles to the journal is foremost on their minds.
Dr. Lebwohl: Yes, I often refer to the JDD in my practice and just to give an example, the update that was published on the 4-year safety data for Ustekinumab (March 2012) is one that I quote to many patients because of the questions raised about immunosuppression. The JDD does a service by making new information available to us, which helps us to give the best care to our patients.
Dr. Lebwohl: The fact that it is free has made the journal much more important. The JDD is circulated to every dermatologist in the world, which is a huge advantage, and the JDD has begun to exceed other journals that are not free.
Dr. Lebwohl: The JDD has had some articles on plant-derived medicine and nutritional supplements that are not usually of interest to me, but looking at them, it was good that they were published. It is good to have some publications in our top journals on non-traditional medicines.
Dr. Lebwohl: More of the same, I like the mix of articles in the JDD and would encourage the editors to keep publishing just as they are.